11 Results for "

glucose-lowering effect

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "glucose-lowering effect" in MCE Product Catalog:

Cat. No.: HY-W005629
CAS No.: 1446-61-3
Leelamine is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor with an IC50 value of 9.5 μM, showing a blood glucose lowering effect in the diabetic mouse. Leelamine is also a weak agonist of cannabinoid receptors CB1 and CB2. Leelamine decreases mitotic activity, prostate-specific antigen expression and induces Apoptosis to cell death in cancer cells .
loading...
    loading...
Cat. No.: HY-N1503
CAS No.: 52613-28-2
Synonyms: 6α-Hydroxygeniposide; Deacetylasperulosidic acid methyl ester
Methyl deacetylasperulosidate (6α-Hydroxygeniposide; Deacetylasperulosidic acid methyl ester) is an iridoid compound that acts as a laxative agent with blood glucose-lowering activity. It induces a laxative effect in mice and lowers blood glucose levels in normal mice .
loading...
    loading...
Cat. No.: HY-N3015
CAS No.: 21586-90-3
Bruceine E is a quassinoid from seeds of Brucea javanica (L.) Merr, exhibiting hypoglycemia effect . Bruceine E exhibits blood glucose lowering effect in both nondiabetic mice and Streptozotocin (STZ (HY-13753))-induced diabetic rats at lower dose .
loading...
    loading...
Cat. No.: HY-148684
CAS No.: 1914176-03-6
Target:  

AMPK

Research Areas:  

Metabolic Disease

AMPK activator 10 is an orally active, potent AMPK activator with EC150 of 44.3 nM by cell-ELISA. AMPK activator 10 increases the phosphorylation levels of ACC. AMPK activator 10 exhibits a glucose lowering effect .
loading...
    loading...
Cat. No.: HY-146468
CAS No.: 2411099-68-6
DPP-4/GPR119 modulator 1 (Compound 22) is an orally active dipeptidyl peptidase IV (DPP-IV) inhibitor and GPR119 agonist. DPP-4/GPR119 modulator 1 shows blood glucose-lowering effect and moderate inhibition on hERG channel with an IC50 of 4.9 μM. DPP-4/GPR119 modulator 1 can be used for diabetes research . DPP-4/GPR119 modulator 1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-162586
CAS No.: 1220965-73-0
Target:  

PDHK

Research Areas:  

Cancer

PDHK-IN-7 (compound 32) is an inhibitor of pyruvate dehydrogenase kinase with an IC50 value of 17 nM.PDHK-IN-7 activates PDH in rat livers and has a glucose-lowering effect in Zucker fatty rats .
loading...
    loading...
Cat. No.: HY-N1503R
CAS No.: 52613-28-2
Synonyms: 6α-Hydroxygeniposide (Standard); Deacetylasperulosidic acid methyl ester (Standard)
Methyl deacetylasperulosidate (Standard) is the analytical standard of Methyl deacetylasperulosidate. This product is intended for research and analytical applications. Methyl deacetylasperulosidate (6α-Hydroxygeniposide; Deacetylasperulosidic acid methyl ester) is an iridoid compound that acts as a laxative agent with blood glucose-lowering activity. It induces a laxative effect in mice and lowers blood glucose levels in normal mice .
loading...
    loading...
Cat. No.: HY-138842
CAS No.: 118006-14-7
Target:  

Insulin Receptor Akt ERK

Research Areas:  

Metabolic Disease

DDN is a selective insulin receptor (Insulin Receptor) activator, an insulin sensitizer, and a glucose-lowering insulin mimetic with oral bioavailability. DDN can directly bind to the receptor kinase domain and induce Akt and ERK phosphorylation, and it can also enhance insulin's effect on glucose uptake. DDN significantly reduces blood glucose levels in wild-type and diabetic ob/ob and db/db mice .
loading...
    loading...
Cat. No.: HY-159491
DPP-4-IN-11 (compound 10) is an orally active DPP-4 inhibitor (IC50=2.75 μM) with anti-type 2 diabetes activity. DPP-4-IN-11 exerts its glucose-lowering effect by inhibiting the activities of α-glucosidase (IC50=3.02 μM) and α-amylase (IC50=3.3 μM) .
loading...
    loading...
Cat. No.: HY-168329
TGR5 agonist 7 (Compound 22-Na) is a gut-restricted, orally active agonist for G protein-coupled bile acid receptor TGR5 (GPBAR1 or GPR131) with an EC50 < 1 μM. TGR5 agonist 7 exhibits blood glucose lowering effect in mouse model, and can be used in diabete research .
loading...
    loading...
Cat. No.: HY-19904B
CAS No.: 872260-19-0
Synonyms: (+)-LY2409021
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

(+)-Adomeglivant ((+)-LY2409021) is a potent and selective glycogenotropin receptor antagonist with glucose-lowering activity. (+)-Adomeglivant reduces fasting blood glucose levels in both healthy subjects and patients with type 2 diabetes. The use of (+)-Adomeglivant can help investigate the mechanisms of hyperglycemia in type 2 diabetes. The antagonistic effect of (+)-Adomeglivant makes it challenging to assess the metabolic consequences of postprandial hyperglycemia .
loading...
    loading...
  • 1